Skip to content
FREE SHIPPING on all orders over $150!
  • Call us 615-469-7778

Turkey Tail Mushrooms - Cancer Adjunctive Support & Immune Interaction

Turkey Tail Mushrooms - Cancer Adjunctive Support & Immune Interaction

Christian Grantham|
A current Phase II clinical trial is investigating whether Turkey Tail mushroom supplementation may help slow tumor proliferation and support immune activity in post-menopausal women with ER+ HER2- breast cancer.

Turkey Tail (Trametes versicolor) has a long history of use in traditional medicine for immune support, and emerging research continues to explore how its compounds interact with cancer therapies and tumor environments.

New Research & Ongoing Clinical Trials in Cancer Context
Although Turkey Tail extracts are not FDA-approved as standalone cancer treatments, there is strong global research interest in their use alongside conventional oncology care. A current Phase II clinical trial is investigating whether Turkey Tail mushroom supplementation can influence tumor behavior in post-menopausal women with HER2-negative, estrogen receptor-positive breast cancer during the period between diagnosis and surgery—building on earlier evidence that supplementation may help slow tumor proliferation and support immune activity in breast cancer patients undergoing treatment.

Beyond this trial, multiple clinical studies across gastrointestinal cancers (including colorectal and gastric cancer) have shown that Turkey Tail polysaccharide extracts like polysaccharide-K (PSK), when used as an adjunct to chemotherapy, can be associated with improved survival outcomes and enhanced immune function compared to conventional therapy alone.

Why This Matters to Everyday Wellness
These findings don’t mean Turkey Tail cures or treats cancer on its own, but they do highlight its potential role as a supportive botanical that interacts positively with immune pathways relevant in oncology settings. PSK, for example, is clinically used in Japan as an adjunctive agent in cancer care and has decades of safety data in patients receiving chemotherapy.

Here’s how its properties translate into broader benefits…

KEY BENEFITS:
• Supports immune system communication and response pathways that may complement conventional therapy
• Provides polysaccharides (like PSK/PSP) studied for supportive effects in cancer care contexts
• May help maintain immune function during conventional cancer treatments

Source for in-depth reading:
Phase II breast cancer clinical trial exploring Turkey Tail as adjunctive therapy: NCI Clinical Trials Search (Phase II Turkey Tail in ER+ HER2- breast cancer) 

This article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.

Back To Blog